Swiss National Bank’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.27M | Sell |
454,000
-4,400
| -1% | -$80.1K | 0.01% | 1018 |
|
|
2025
Q1 | $9.09M | Hold |
458,400
| – | – | 0.01% | 945 |
|
|
2024
Q4 | $7.86M | Buy |
458,400
+28,500
| +7% | +$489K | 0.01% | 1063 |
|
|
2024
Q3 | $8.59M | Sell |
429,900
-3,000
| -0.7% | -$60K | 0.01% | 1017 |
|
|
2024
Q2 | $4.84M | Buy |
432,900
+11,800
| +3% | +$132K | ﹤0.01% | 1301 |
|
|
2024
Q1 | $2.78M | Hold |
421,100
| – | – | ﹤0.01% | 1648 |
|
|
2023
Q4 | $1.9M | Sell |
421,100
-18,700
| -4% | -$84.5K | ﹤0.01% | 1869 |
|
|
2023
Q3 | $1.57M | Buy |
439,800
+4,300
| +1% | +$15.4K | ﹤0.01% | 1983 |
|
|
2023
Q2 | $1.61M | Buy |
435,500
+12,500
| +3% | +$46.1K | ﹤0.01% | 2032 |
|
|
2023
Q1 | $1.4M | Sell |
423,000
-49,300
| -10% | -$163K | ﹤0.01% | 2052 |
|
|
2022
Q4 | $1.83M | Buy |
+472,300
| New | +$1.83M | ﹤0.01% | 1948 |
|